The Degradation Rate and Osteoinductive Efficacy of BMP-2-Bearing Biomimetic Coatings Vary as a Function of the Drug Delivery Mode

Abstract:

Article Preview

Info:

Periodical:

Key Engineering Materials (Volumes 309-311)

Main Theme:

Edited by:

Takashi Nakamura, Kimihiro Yamashita and Masashi Neo

Pages:

969-972

Citation:

Y. L. Liu et al., "The Degradation Rate and Osteoinductive Efficacy of BMP-2-Bearing Biomimetic Coatings Vary as a Function of the Drug Delivery Mode ", Key Engineering Materials, Vols. 309-311, pp. 969-972, 2006

Online since:

May 2006

Export:

Price:

$38.00

[1] Jansen J.A., Vehof J.W.M., Ruhé P.Q., Kroeze-Deutman H., Kuboki Y., Takita H., Hedberg E.L. and Mikos A.G. J Control Release, 2005 101(1-3): 127-36.

DOI: https://doi.org/10.1016/j.jconrel.2004.07.005

[2] Hollinger J.O., Leong K., Biomaterials, 1996; 17: 187-194.

[3] Ono I., Gunji H, Kaneko F., Saito T., and Kuboki Y. J Craniofac Surg, 1995; 6(3): 238-44.

[4] Kirker-Head C.A. Adv Drug Deliv Rev, 2000; 43: 65.

[5] Liu Y., Hunziker E. B., de Groot K., Bone, 2005; 36: 745-757.

[6] Liu Y., Hunziker E. B., Van de Vaal C., de Groot K., Bioceramics, 2003; 16: 619-622. 0 2 4 6 8 10 12 14 16 18.

[2] 5µg 5. 0µg 7. 5µg Amount of BMP-2 adsorbed (µg/implant) 1 week 2 weeks 3 weeks.